Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Rawla, Prashanth, Sunkara, Tagore, Gaduputi, Vinaya·2019·World Journal of Oncology

DOI 10.14740/wjon1166

Cited by (1,002)

Items 601–700 of 1,002

A radiomics model that predicts lymph node status in pancreatic cancer to guide clinical decision making: A retrospective study
Xiaoyuan Liang, Wei Cai, Xingyu Liu, Ming Li Jin, Ling-xiang Ruan, Sheng Yan · 2021 · Journal of Cancer
Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer
Miguel Angel Ortega, Oscar Fraile‐Μartinez, Leonel Pekarek, Cielo García Montero, Miguel Ángel Álvarez-Mon, Alejandro J. Castellanos, Natalio García‐Honduvilla, Julia Buján, Melchor Álvarez‐Mon, Miguel A. Sáez et al. · 2022 · Antioxidants
Timosaponin A3 Inhibits Palmitate and Stearate through Suppression of SREBP-1 in Pancreatic Cancer
Yumi Kim, Wona Jee, Eun-Jin An, Hyun Min Ko, Ji Hoon Jung, Yun‐Cheol Na, Hyeung-Jin Jang · 2022 · Pharmaceutics
Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview
Abdullah K. Alshememry, Nasser B. Alsaleh, Nora A. Alkhudair, Rami M. Alzhrani, Aws Alshamsan · 2022 · Frontiers in Pharmacology
Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models
Yang Kee Stella Man, Carmen Aguirre Hernandez, Adrian Fernandez, Pilar Martín‐Duque, Rebeca González‐Pastor, Gunnel Halldén · 2022 · International Journal of Molecular Sciences
Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals
Tahmina Nasrin Poly, Md. Mohaimenul Islam, Bruno Andreas Walther, Ming‐Chin Lin, Yu-Chuan Li · 2022 · Cancers
Pancreatic cancer survival trends in the US from 2001 to 2014: a CONCORD‐3 study
Maja Nikšić, Pamela Minicozzi, Hannah K. Weir, Heather A. Zimmerman, Maria J. Schymura, Judith R Rees, Michel P. Coleman, Claudia Allemani, US CONCORD Working Group · 2022 · 癌症：英文版
Screening of MMP-2 Inhibiting Phytoconstituents for the Development of Newer Pancreatic Cancer Treatment Modalities
Loganayaki Periyasamy, Muruganantham Bharathi, Sundaraj Rajamanikandan, Sneha Krishnamoorthi, Sridhar Muthusami · 2023 · Protein and Peptide Letters
Analysis of the fecal metagenome in long‐term survivors of pancreas cancer
Jordan R. Kharofa, David B Haslam, Rachael Wilkinson, Allison Weiss, Sameer H. Patel, Kyle Wang, Hope R Esslinger, Olugbenga Olanrele Olowokure, Davendra P. S. Sohal, Greg C. Wilson et al. · 2023 · Cancer
Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer
Anelis Maria Marin, Michel Batista, Alexandre Luiz Korte de Azevedo, Talita Helen Bombardelli Gomig, Rodrigo Soares Caldeira Brant, Roger J. Chammas, Miyuki Uno, Diogo Dias Araújo, Dalila Lucíola Zanette, Mateus Nóbrega Aoki · 2023 · International Journal of Molecular Sciences
Treatment sequences and prognostic/predictive factors in metastatic pancreatic ductal adenocarcinoma: univariate and multivariate analyses of a real-world study in Europe
Julien Taı̈eb, Thomas Theodor Werner Seufferlein, Michele Reni, Daniel H. Palmer, John A. Bridgewater, Antonio Cubillo, Gerald W. Prager, Alice Vermeire, Fabienne Hédouin-Biville, Zhaoyang Teng et al. · 2023 · BMC Cancer
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer
Mi Rim Lee, Sang Myung Woo, Min Kyeong Kim, Sung‐Sik Han, Sang‐Jae Park, Woo Jin Lee, Dong-Eun Lee, Sung Yong Choi, Wonyoung Choi, Kyong‐Ah Yoon et al. · 2024 · Cancer Science
DOTA‐Based Plectin‐1 Targeted Contrast Agent Enables Detection of Pancreatic Cancer in Human Tissue
Thais Gazzi, Marina Lesina, Qinghua Wang, Alexandra Berninger, Silke Radetzki, İhsan Ekin Demir, Larissa Kohlmann, Waldemar Meiser, Sebastian Wilke, Jens Peter von Kries et al. · 2024 · Angewandte Chemie International Edition
Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis
Brian Shiian Chen, Shu‐Yen Chan, Fernand Bteich, Chaoyuan Kuang, Jeffrey A. Meyerhardt, Kevin Sheng‐Kai · 2024 · Critical Reviews in Oncology/Hematology
Placental growth factor promotes neural invasion and predicts disease prognosis in resectable pancreatic cancer
Andreas Göhrig, Georg Hilfenhaus, Friederike Rosseck, Martina Welzel, Benjamin Moser, Gianluca Barbone, Catarina Alisa Kunze, Johannes Rein, Gregor Wilken, Michael Böhmig et al. · 2024 · Journal of Experimental & Clinical Cancer Research
Effect of Angelica gigas Nakai Ethanol Extract and Decursin on Human Pancreatic Cancer Cells
Bitna Kweon, Yohan Han, Ji‐Ye Kee, Jeong‐Geon Mun, Hee Dong Jeon, Dae Hwan Yoon, Byung‐Min Choi, Seung‐Heon Hong · 2020 · Molecules
Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review
Raëf Abdallah, Valérie Taly, Shulin Zhao, Daniel Pietrasz, Jean‐Baptiste Bachet, Debora Basile, Léo Mas, Aziz Zaanan, Pierre Laurent‐Puig, Julien Taı̈eb · 2020 · Cancer Treatment Reviews
Dynamic behaviour and stabilisation to boost the immune system by complex interaction between tumour cells and vitamins intervention
Sana Abdulkream Alharbi, Azmin Sham Rambely · 2020 · Advances in Difference Equations
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer
Ji Hun Kang, Seung Soo Lee, Jin Hee Kim, Jae Ho Byun, Hyoung Jung Kim, Changhoon Yoo, Kyu‐pyo Kim, Baek‐Yeol Ryoo, Song Cheol Kim · 2020 · European Radiology
Five gene signatures were identified in the prediction of overall survival in resectable pancreatic cancer
Chao Wu, Zuowei Wu, Bole Tian · 2020 · BMC Surgery
Mercury in Pancreatic Cells of People with and without Pancreatic Cancer
Roger Pamphlett, Andrew J. Colebatch, Philip Doble, David Bishop · 2020 · International Journal of Environmental Research and Public Health
The role of intraperitoneal chemotherapy in the surgical management of pancreatic ductal adenocarcinoma: a systematic review
Alexandre Brind’Amour, Mitchell A. Webb, Marina L. Parapini, Lucas Sidéris, Maja Segedi, Stephen W. Chung, Stéphanie Chartier-Plante, Pierre Dubé, Charles H. Scudamore, Peter T. W. Kim · 2021 · Clinical & Experimental Metastasis
Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3
Evelina Mocci, Prosenjit Kundu, William Wheeler, Alan A. Arslan, Laura E. Beane-Freeman, Paige M. Bracci, Paul Brennan, Federico Canzian, Mengmeng Du, Steve Gallinger et al. · 2021 · Cancer Research
Mitofusin-2 is a novel anti-angiogenic factor in pancreatic cancer
Zhichuan Lin, Xiaoyi Lin, Jinhong Chen, Guoqiang Huang, Tangen Chen, Liling Zheng · 2021 · Journal of Gastrointestinal Oncology
PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma
Sara Tartaglione, Patrizia Mancini, Valentina Viggiani, Piero Chirletti, Antonio Angeloni, Emanuela Anastasi · 2021 · PLoS ONE
Differentiating TP53 Mutation Status in Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI-Derived Radiomics
Jing Gao, Xiahan Chen, Xudong Li, Fei Miao, Weihuan Fang, Biao Li, Xiaohua Qian, Xiaozhu Lin · 2021 · Frontiers in Oncology
Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
Maria Dobre, Vlad Herlea, Cătălina Vlăduţ, Mihai Ciocîrlan, Daniel Vasile Balaban, Gabriel Constantinescu, Mircea Diculescu, Elena Milanesi · 2021 · Cells
Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
Evelien J.M. de Jong, Quisette P. Janssen, Tessa F. A. Simons, Marc G. Besselink, Bert A. Bonsing, Stefan A.W. Bouwense, Sandra M. E. Geurts, Marjolein Y.V. Homs, Vincent Erwin de Meijer, Vivianne C. G. Tjan‐Heijnen et al. · 2021 · International Journal of Cancer
High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer
Abhinav V. Reddy, Colin Hill, Shuchi Sehgal, Jin Peng He, Lei Zheng, Joseph M. Herman, Jeffrey John Meyer, Amol Kumar Narang · 2021 · Journal of Gastrointestinal Oncology
A Low Dose of Pure Cannabidiol Is Sufficient to Stimulate the Cytotoxic Function of CIK Cells without Exerting the Downstream Mediators in Pancreatic Cancer Cells
Francesca Garofano, Amit Sharma, Hinrich Abken, Maria Angeles Gonzalez-Carmona, Ingo G.H. Schmidt‐Wolf · 2022 · International Journal of Molecular Sciences
Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review
Milly Buwenge, ALESSANDRA ARCELLI, Francesco Cellini, Francesco Deodato, Gabriella Macchia, Savino Cilla, Erika Galietta, Lidia Strigari, Claudio Malizia, S. Cammelli et al. · 2022 · Current Oncology
Investigation of the effects of the toll-like receptor 4 pathway on immune checkpoint vista in pancreatic cancer
Kübra Sena Baş Topcu, Emine Nedime Korucu, Esma Menevşe, Nadir Koçak, Tuğçe Duran · 2022 · Investigational New Drugs
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin Hill, Shuchi Sehgal, Lei Zheng, Jin Peng He, Daniel A. Laheru, Ana De Jesus‐Acosta, Joseph M. Herman, Jeffrey John Meyer, Amol Kumar Narang · 2022 · Radiation Oncology Journal
The Effect of Oncogene Proteins of Human Papillomaviruses on Apoptosis Pathways in Prostate Cancer
Robabeh Faghany Baladehi, Mohammad Yousef Memar, Abolfazl Jafari-Sales, Ahad Bazmani, Javid Sadri Nahand, Parisa Shiri Aghbash, Hossein Bannazadeh Baghi · 2022 · ONCOLOGIE
Marine-Inspired Drugs and Biomaterials in the Perspective of Pancreatic Cancer Therapies
Andréia Miranda Fernandes, Catarina Oliveira, Rui Luís Reis, Albino M Martins, Tiago Henriques Silva · 2022 · Marine Drugs
Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma
Beatriz Parejo-Alonso, Alba Royo-García, Pilar Espiau-Romera, Sarah Courtois, Álvaro Curiel‐García, Sladjana Zagorac, Isabel Villaoslada, Kenneth P. Olive, Christopher Heeschen, Patricia Sancho · 2022 · Biomedicine & Pharmacotherapy
Pancreatic Cancer Resistance to Treatment: The Role of Microbiota
Enrico Celestino Nista, Angelo DEL GAUDIO, Livio Enrico Del Vecchio, Teresa Mezza, Giulia Pignataro, Andrea Piccioni, Antonio Gasbarrini, Francesco Franceschi, Marcello Candelli · 2023 · Biomedicines
Epidemiology of pancreatic cancer
Belma Muratović, Aleksandra Nikolić · 2023 · Zdravstvena zastita
Magnetite Nanoparticle Photothermal Therapy in a Pancreatic Tumor-on-Chip: A Dual-Action Approach Targeting Cancer Cells and their Microenvironment
Anastasiia Dubrova, Charles Cavaniol, Aurore Van de Walle, Paul Mathieu, Zoé Fusilier, Nader Yaacoub, Yoann Lalatonne, Stéphanie Descroix, Claire Wilhelm · 2025 · ACS Nano
Attenuated regimen of biweekly gemcitabine/nab-paclitaxel in patients aged 65 years or older with advanced pancreatic cancer
Hasan Rehman, Jeffrey Chi, Nausheen Hakim, Shreya Prasad Goyal, Coral Olazagasti, Jyothi Jose, Linda Moriarty, M. W. Saif · 2020 · Therapeutic Advances in Gastroenterology
Carbon ion radiotherapy as definitive treatment in locally recurrent pancreatic cancer
Jakob Liermann, Edgar Ben‐Josef, Mustafa Syed, Jürgen Debus, Klaus K Herfarth, Patrick Naumann · 2021 · Strahlentherapie und Onkologie
Alloferon Affects the Chemosensitivity of Pancreatic Cancer by Regulating the Expression of SLC6A14
Hyejung Jo, Da Young Lee, Cheolhyeon Go, Yoojin Jang, Suhyun Bae, Tomoyo Agura, Jiye Hong, Dongmin Kang, Yejin Kim, Jae Seung Kang · 2022 · Biomedicines
Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk
Simran Arjani, Pedro F. Saint‐Maurice, Sachelly Julián‐Serrano, Guido Eibl, Rachael Z. Stolzenberg‐Solomon · 2022 · JNCI Cancer Spectrum
Fasting blood glucose and risk of incident pancreatic cancer
Young Jin Kim, Chang‐Mo Oh, Sung Keun Park, Ju Young Jung, Min Ho Kim, Eun‐Hee Ha, Do Jin Nam, Yeji Kim, Eun Hye Yang, Hyo Choon Lee et al. · 2022 · PLoS ONE
Race, Insurance, and Sex-Based Disparities in Access to High-Volume Centers for Pancreatectomy
Catherine G. Williamson, Shayan Ebrahimian, Sara Sakowitz, Esteban Aguayo, Elsa Kronen, Timothy R. Donahue, Peyman Benharash · 2023 · Annals of Surgical Oncology
Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography – the next dimension of diagnosis
Diana Pinkert‐Leetsch, Jasper Frohn, Philipp Ströbel, Frauke Alves, Tim Salditt, Jeannine Missbach‐Guentner · 2023 · Cancer Imaging
Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
Gabriela Reyes‐Castellanos, Nadine Abdel Hadi, Scarlett Gallardo-Arriaga, Rawand Masoud, Julie Garcia, Sophie Lac, Abdessamad El Kaoutari, Tristan Gicquel, Mélanie Planque, Sarah‐Maria Fendt et al. · 2023 · iScience
Prognostic Value of Alkaline Phosphatase and Gamma-Glutamyl Transferase in Patients with Metastatic Pancreatic Cancer
Martina Catalano, Giandomenico Roviello, Giuseppe Aprile, Monica Ramello, Raffaele Conca, Roberto Petrioli, Gabriele Perrone, Anna Ianza, Enrico Mini · 2023 · Future Oncology
The Link between Diabetes, Pancreatic Tumors, and miRNAs—New Players for Diagnosis and Therapy?
Małgorzata Kozłowska, Agnieszka Śliwińska · 2023 · International Journal of Molecular Sciences
CRISPR/Cas9-mediated knock-in of BRCA1/2 mutations restores response to olaparib in pancreatic cancer cell lines
Andréa Witz, Julie Dardare, Aurélie François, Marie Husson, Marie Rouyer, Jessica Demange, Jean‐Louis Merlin, Pauline Gilson, Alexandre Harlé · 2023 · Scientific Reports
Comparison Between Plastic and Metallic Biliary Stent Placement for Preoperative Patients with Pancreatic Head Cancer: A Systematic Review and Meta-Analysis
Yutaka Endo, Masayuki Tanaka, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Yasushi Hasegawa, Shutaro Hori, Yutaka Nakano, Eisuke Iwasaki, Yuko Kitagawa · 2023 · Annals of Surgical Oncology
Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer
Hui Deng, Hanming Yao, Shurui Zhou, Chong He, Yuzhou Huang, Yunlong Li, Hanwei Chen, Jianchang Shu · 2023 · Molecular and Cellular Probes
Sialylated glycoproteins and sialyltransferases in digestive cancers: Mechanisms, diagnostic biomarkers, and therapeutic targets
Shao-Ze Zhang, A J Lobo, Peifeng Li, Yinfeng Zhang · 2024 · Critical Reviews in Oncology/Hematology
Current status of preoperative endoscopic biliary drainage for distal and hilar biliary obstruction
Hirotoshi Ishiwatari, Junya Sato, Hiroki Sakamoto, Takuya Doi, Hiroyuki Ono · 2024 · Digestive Endoscopy
Insights into gemcitabine resistance in pancreatic cancer: association with metabolic reprogramming and TP53 pathogenicity in patient derived xenografts
Mariam M. Konaté, Julia Krushkal, Ming‐Chung Li, Li Chen, Yuri Kotliarov, Alida Palmisano, Rini Pauly, Qian Xie, Paul Mickey Williams, Lisa M. McShane et al. · 2024 · Journal of Translational Medicine
Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study
Kazunori Nakaoka, Eizaburo Ohno, Kento Kuramitsu, Teiji Kuzuya, Kohei Funasaka, Takumi Tochio, Tadashi Fujii, Hideaki Takahashi, Nobuhiro Kondo, Ryoji Miyahara et al. · 2024 · Nutrients
Machine learning algorithms and biomarkers identification for pancreatic cancer diagnosis using multi-omics data integration
Arian Karimi Rouzbahani, Ghazaleh Khalili‐Tanha, Yasamin Rajabloo, Fatemeh Khojasteh‐Leylakoohi, Hassan Shokri Garjan, Elham Nazari, Amir Avan · 2024 · Pathology - Research and Practice
Omics Approaches in Pancreatic Adenocarcinoma
Iranzu González‐Borja, Antonio Viúdez, Saioa Goñi, Enrique Santamaría, Estefanía Carrasco‐García, Jairo Pérez‐Sanz, Irene Hernández-García, Pablo Sala Elarre, Virginia Arrazubi, Esther Oyaga-Iriarte et al. · 2019 · Cancers
Pancreatic cancer trends in Europe: epidemiology and risk factors
Graeme Hawksworth, Jake Hales, Fransico Martinez, Allen Hynes, Angela Hamilton, Verónica Fernández · 2019 · Medical Studies
Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
Chaobin He, Jun Wang, Yu Zhang, Zhiyuan Cai, Xiaojun Lin, Shengping Li · 2020 · Cancer Medicine
Inhibition of Migration, Invasion and Drug Resistance of Pancreatic Adenocarcinoma Cells – Role of Snail, Slug and Twist and Small Molecule Inhibitors
Ezgi Kaşıkcı, Esra Aydemir, Ömer Faruk Bayrak, Fikrettin Şahi̇n · 2020 · OncoTargets and Therapy
Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL)
Wode, Kathrin, Hök Nordberg, Johanna, Kienle, Gunver S., Elander, Nils O., Bernhardson, Britt-Marie, Sunde, Berit, Sharp, Lena, Henriksson, Roger, Fransson, Per · 2020 · Trials
Robotic versus open pancreaticoduodenectomy: Is there any difference for frail patients?
Claudia Paolini, Lapo Bencini, Linda Gabellini, Irene Urciuoli, Sabrina Pacciani, Angela Tribuzi, Luca Moraldi, Massimo Calistri, Andrea Coratti · 2021 · Surgical Oncology
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX study
Jaime Feliú, Mónica Jorge Fernández, Teresa Mercade Macarulla, Bartomeu Massutí, Ana Albero, José Federico González González, Guillermo Quintero Aldana, Juan Ignacio Delgado-Mingorance, Ana Fernández Montés, C García Piernavieja et al. · 2021 · Cancer Chemotherapy and Pharmacology
Minimally Invasive Pancreaticoduodenectomy in Elderly Patients: Systematic Review and Meta‐Analysis
Jisheng Zhu, Guiyan Wang, Peng Du, Jianpeng He, Yong Li · 2021 · World Journal of Surgery
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study
Elisa Conde, Julie Earl, Lorena Crespo-Toro, Carolina Blanco-Agudo, Edurne Ramos, Esperanza Macarena Rodríguez-Serrano, José Carlos Martínez Ávila, Laura Salinas-Muñoz, Silvia Serrano Huertas, Reyes Ferreiro et al. · 2021 · Cancers
KRAS, A Prime Mediator in Pancreatic Lipid Synthesis through Extra Mitochondrial Glutamine and Citrate Metabolism
Isaac James Muyinda, Jae Gwang Park, Eunjung Jang, Byong Chul Yoo · 2021 · International Journal of Molecular Sciences
First Course of treatment and Prognosis of Exocrine Pancreatic Cancer in Korea from 2006 to 2017
Mee Joo Kang, Jiwon Lim, Sung‐Sik Han, Hyeong Min Park, Sang‐Jae Park, Young‐Joo Won, Sun‐Whe Kim · 2021 · Cancer Research and Treatment
Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma
Junhao Xie, Xianzhu Zhou, Rui Wang, Jiulong Zhao, Jian Tang, Qichen Zhang, Yiqi Du, Yanan Pang · 2021 · Medicine
Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer
Madeline T. Olson, Eric N. Aguilar, Cory L. Brooks, Carly C. Isder, Kathryn M. Muilenburg, Geoffrey A. Talmon, Quan P. Ly, Mark A. Carlson, Michael Anthony Hollingsworth, Aaron M. Mohs · 2022 · Molecular Pharmaceutics
Current status of inherited pancreatic cancer
Marek Olakowski, Łukasz Bułdak · 2022 · Hereditary Cancer in Clinical Practice
IGF1 receptor-targeted black TiO2 nanoprobes for MRI-guided synergetic photothermal-chemotherapy in drug resistant pancreatic tumor
Kaiwei Xu, Lufei Jin, Xu Liu, Yuchao Zhu, Lu Hong, Chunshu Pan, Yanying Li, Junlie Yao, Ruifen Zou, Weiwei Tang et al. · 2022 · Journal of Nanobiotechnology
iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells
Boris Sieber, Fangfang Lu, Stephen M. Stribbling, Adam Graham Grieve, Anderson Joseph Ryan, Matthew Freeman · 2022 · Journal of Cell Science
Pancreatic Cancer: Current Situation and Challenges
Cheng Jin, Ling Bai · 2020 · Gastroenterology & Hepatology Letters
Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitors
Pascal R. Hammel, Carole Vitellius, Émeric Boisteau, Mathilde Wisniewski, Elise Colle, Marc Hilmi, Christelle d’Engremont, Sandra Granier, Anthony Turpin, Louis de Mestier et al. · 2020 · Therapeutic Advances in Medical Oncology
Water Soluble Iron-Based Coordination Trimers as Synergistic Adjuvants for Pancreatic Cancer
Marco Cordani, Esther Resines‐Urien, Arturo Gamonal, Paula Milán-Rois, Lionel Salmon, Azzedine Bousseksou, José Sánchez Costa, Álvaro Somoza · 2021 · Antioxidants
An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
Ye, Qingmei, Zhou, Xin, Ren, Han, Han, Fangxuan, Lin, Rong, Li, Juan · 2023 · Frontiers in Pharmacology
ROR1 and ROR2 expression in pancreatic cancer
Dongli Liu, George Sharbeen, Phoebe A. Phillips, Australian Pancreatic Cancer Genome Initiative, Amber L. Johns, Anthony James Gill, Lorraine A. Chantrill, Paul Timpson, Angela S. Y. Chou, Marina Pajic et al. · 2021 · BMC Cancer
Inclusion of cancer-associated fibroblasts in drug screening assays to evaluate pancreatic cancer resistance to therapeutic drugs
Sarah Brumskill, Lawrence N. Barrera, Peter J. Calcraft, Caroline Phillips, Eithne Costello · 2021 · Journal of Physiology and Biochemistry
Protein Tyrosine Phosphatase 1B (PTP1B): Insights into its New Implications in Tumorigenesis
Peijie Chen, Yuntian Zhang · 2022 · Current Cancer Drug Targets
Current Pathology Model of Pancreatic Cancer
K Szymoński, Katarzyna Milian-Ciesielska, Ewelina W. Lipiec, Dariusz Adamek · 2022 · Cancers
Retinoic acid receptor gamma is required for proliferation of pancreatic cancer cells
Kaiyuan Ji, Wenlong Dou, Ningfang Zhang, Bolun Wen, Mingyan Zhong, Qianbing Zhang, Shuxiang Xu, Jianlong Zhou, Jingfeng Liu · 2022 · Cell Biology International
CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
Hanzhang Zhu, Weijiang Zhou, Yafeng Wan, Jun Lu, Ke Ge, Changku Jia · 2022 · International Journal of Molecular Sciences
Circulating gamma‐glutamyl transpeptidase and risk of pancreatic cancer: A prospective cohort study in the UK Biobank
Weiting Liao, Yang Yu, Huazhen Yang, Yuanyuan Qu, Huan Song, Qiu Li · 2022 · Cancer Medicine
Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures
Xuan Zou, Yu Liu, Xuan Lin, Ruijie Wang, Zhengjie Dai, Yusheng Chen, Mingjian Ma, Yesiboli Tasiheng, Yu Yan, Xu Wang et al. · 2023 · Cancers
Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
Shaila A. Shetu, Nneoma James, Gildardo Rivera, Debasish Bandyopadhyay · 2023 · Current Issues in Molecular Biology
Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer
Feda H. Hamdan, Amro M. Abdelrahman, Ana P. Kutschat, Xin Wang, Thomas L. Ekstrom, Nidhi Jalan‐Sakrikar, Catherine Wegner Wippel, Negar Taheri, Liezel Tamon, Waltraut Kopp et al. · 2023 · Gut
Personalized multimodal prehabilitation reduces cardiopulmonary complications after pancreatoduodenectomy: results of a propensity score matching analysis
Allard G Wijma, Frederik J.H. Hoogwater, Maarten W. Nijkamp, Joost M. Klaase · 2023 · HPB
A phantom to simulate organ motion and its effect on dose distribution in carbon ion therapy for pancreatic cancer
Christina Stengl, Kathrin Panow, Eric Arbes, Iván Domingo Muñoz, Jeppe Brage Christensen, Christian Jan Oliver Neelsen, Fabian Dinkel, Artur Weidner, Armin Runz, W. Johnen et al. · 2023 · Physics in Medicine and Biology
Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives
Belén Toledo, Chiara Deiana, Fabio Scianò, Giovanni Brandi, Juan Antonio Marchal, Macarena Perán, Elisa Giovannetti · 2024 · Expert Review of Clinical Pharmacology
Chitosan and Its Derivative‐Based Nanoparticles in Gastrointestinal Cancers: Molecular Mechanisms of Action and Promising Anticancer Strategies
Zahra Shokati Eshkiki, Fatemeh Mansouri, Amir Reza Karamzadeh, Abolfazl Namazi, Hafez Heydari, Javad Akhtari, Seidamir Pasha Tabaeian, Abolfazl Akbari · 2024 · Journal of Clinical Pharmacy and Therapeutics
Targeting Neoantigens in Pancreatic Ductal Adenocarcinoma
Gurkaranjot Singh, Drew Kutcher, Rajeshwar Lally, Vikrant Rai · 2024 · Cancers
Blood-Based Multi-Cancer Early Detection Tests (MCEDs) as a Potential Approach to Address Current Gaps in Cancer Screening
Chantelle Carbonell, John M. Hutchinson, Robert J. Hilsden, Huiming Yang, Darren R. Brenner · 2024 · Cancer Control
Prophylactic total pancreatectomy in individuals at high risk of pancreatic ductal adenocarcinoma (PROPAN): systematic review and shared decision‐making programme using decision tables
Lianne Scholten, Anouk E.J. Latenstein, Cora M. Aalfs, Marco J. Bruno, Olivier R. Busch, Bert A. Bonsing, Bas Groot Koerkamp, Izaak Quintus Molenaar, Dirk T. Ubbink, Jeanin Elise van Hooft et al. · 2020 · United European Gastroenterology Journal
Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid
Stefano Rossetti, Nicoletta Sacchi · 2020 · Cancers
Radioactive 125I seed implantation for locally advanced pancreatic cancer: A retrospective analysis of 50 cases
Chenggang Li, Zhipeng Zhou, Yüze Jia, Xiang-Long Tan, Yuyao Song · 2020 · World Journal of Clinical Cases
RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer
Frank Arnold, Johann Gout, Heike Wiese, Stephanie Ellen Weissinger, Élodie Roger, Lukas Perkhofer, Karolin Walter, Jeanette Scheible, Caterina Prelli Bozzo, André Lechel et al. · 2021 · Cancer Research
Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models
Owen Hoare, Nicolas Alejandro Fraunhoffer, Abdessamad El Kaoutari, Odile Gayet, Martin Bigonnet, Julie Roques, Rémy Nicolle, COLIN P. McGUCKIN, Nico Forraz, Emilie Sohier et al. · 2021 · Cancers
Identifying symptoms associated with diagnosis of pancreatic exocrine and neuroendocrine neoplasms: a nested case-control study of the UK primary care population
Weiqi Liao, Ashley Kieran Clift, Martina Patone, Carol A. C. Coupland, Arturo González-Izquierdo, Stephen P. Pereira, Julia Hippisley‐Cox · 2021 · British Journal of General Practice
Sociodemographic index and global trends in prostate cancer: 1990–2017
Bryn M. Launer, Granville L. Lloyd · 2021 · The Prostate